Morgan Stanley Re Shape Lifesciences Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.32 - $15.6 $24 - $1,185	76 Added 1900.0%	80 $0
Q2 2022 Oct 27, 2022	SELL	$0.56 - $1.25 $8 - $18	-15 Reduced 78.95%	4 $0
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.25 $8 - $18	-15 Reduced 78.95%	4 $0
Q1 2022 Oct 27, 2022	BUY	$0.86 - $1.86 $12 - $27	15 Added 375.0%	19 $0
Q1 2022 May 13, 2022	SELL	$0.86 - $1.86 $1,124 - $2,432	-1,308 Reduced 98.57%	19 $0
Q4 2021 Feb 14, 2022	SELL	$1.64 - $3.13 $170,458 - $325,325	-103,938 Reduced 98.74%	1,327 $2,000
Q3 2021 Nov 15, 2021	BUY	$2.67 - $5.09 $281,057 - $535,798	105,265 New	105,265 $303,000

Ticker RSLS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,559,400
Market Cap $130M
Description
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.